CAR-T cells are an expensive form of cancer treatment, but other techniques may soon supplant them, Elizabeth Tracey reports
All Podcasts – Johns Hopkins Medicine Podcasts
July 7, 20251m 5s
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
CAR-T cells, a highly activated immune cell, have been used to treat a solid tumor, stomach cancer, for the first time. Yet the fact remains that CAR-Ts are expensive and time consuming to produce. Johns Hopkins Kimmel Cancer Center director …